The forecast for the import of streptomycins to Brazil shows a consistent downward trend from 2024 to 2028. In 2024, the imports are valued at $592.34 thousand, with a steady decrease each subsequent year, reaching $417.81 thousand by 2028. The year-over-year percentage decline highlights a significant contraction, indicating a diminishing demand or increasing competition from alternative solutions. The compound annual growth rate (CAGR) over these five years underscores a notable average annual reduction.
Future trends to watch for include potential changes in domestic production capabilities, shifts in governmental health policies, increased competition from other pharmaceuticals, and global supply chain dynamics that could influence the volume and value of streptomycin imports. Monitoring these factors could offer insights into market adjustments and needs.
